Lung injuries are leading causes of morbidity and mortality worldwide. Pulmonary diseases such as asthma or chronic obstructive pulmonary disease characterized by loss of lung elasticity, small airway tethers, and luminal obstruction with inflammatory mucoid secretions, or idiopathic pulmonary fibrosis characterized by excessive matrix deposition and destruction of the normal lung architecture, have essentially symptomatic treatments and their management is costly to the health care system.
Regeneration of tissue by stem cells from endogenous, exogenous, and even genetically modified cells is a promising novel therapy. The use of adult stem cells to help with lung regeneration and repair could be a newer technology in clinical and regenerative medicine. In fact, different studies have shown that bone marrow progenitor cells contribute to repair and remodeling of lung in animal models of progressive pulmonary hypertension.
Therefore, lung stem cell biology may provide novel approaches to therapy and could represent a great promise for the future of molecular medicine. In fact, several diseases can be slowed or even blocked by stem cell transplantation.
Benjamin, D.K. et al. (2002) Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J21: 227-234.
2.
Beyer Nardi, N. and da Silva Meirelles, L. (2006) Mesenchymal stem cells: Isolation, in vitro expansion and characterization. Handb Exp Pharmacol174: 249-282.
3.
Carla, F. (2007) Kim, Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells, Am J Physiol Lung Cell Mol Physiol293(5): L1092-L1098.
4.
Conese, M. and Rejman, J.J. (2006) Stem cells and cystic fibrosis. J Cyst Fibros3: 141-143.
5.
Eastham, A.M. et al. (2007) Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res67(23): 11254-11262.
6.
Engelhard, D. et al. (2002) Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol117: 444-450.
7.
European Lung Foundation.Economic Impact . www.european-lung-foundation.org
8.
European Lung Foundation.Lung Diseases. www.european-lung-foundation.org
9.
Freudenberger, T.D. et al. (2003) Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood102(10): 3822-3828.
10.
Gazdhar, A. (2007) Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro. Stockholm, Sweden, European Respiratory Society Congress, pp. 718s-719s.
11.
Giangreco, A. et al. (2007) Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med117(10): 2929-2940.
12.
Giordano, A. et al. (2007) From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol211: 27-35.
13.
Hedrick, M.H. and Deniels, E.J. (2003) The use of adult stem cell in regenerative medicine . Clin Plastic Surg30: 499-505.
14.
Hildebrandt, G.C. et al. (2008) Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant14(1): 67-74.
15.
Hogg, J.C. (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet364(9435): 709-721.
16.
Kim, C.B. (2007) Advancing the field of lung stem cell biology. Front Biosci12: 3117-3124.
17.
Kim, C.F.B. (2005) Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer. Cell121: 823-835.
18.
Kirkham, P. et al. (2006) Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacology & Therapeutics111(2): 476-494.
19.
Kotton, D.N. et al. (2004) Lung stem cells: new paradigms. Exp Hematol32: 340-343.
20.
Lane, S. et al. (2007) Embryonic stem cell engraftment in healthy and injured mouse lung. Stockholm, Sweden, European Respiratory Society Congress, pp. 719s-720s.
21.
Le Blanc, K. and Pittenger, M. (2005) Mesenchymal stem cells: progress toward promise . Cytotherapy7: 36-45.
22.
Liu, X. (2006) Stem cells in the lung. Methods Enzymol419: 285-321.
23.
Loebinger, M.R. et al. (2008) Therapeutic potential of stem cells in lung disease: progress and pitfalls. Clin Sci (Lond)114(2): 99-108.
24.
Loebinger, M.R. and Janes, S.M. (2007) Stem cells for lung disease. Chest132: 279-285.
25.
MacCallum, N.S. and Evans, T.W. (2005) Epidemiology of acute lung injury. Curr Opin Crit Care11(1): 43-49.
26.
27.
Olsson, F. et al. (2007) Deriving respiratory cell types from stem cells. Curr Stem Cell Res Ther2(3): 197-208.
28.
Phinney, D.G. and Isakova, I. (2005) Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des11: 1255-1265.
29.
Randell, S.H. (2006) Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc3: 718-725.
30.
Reya, T. et al. (2001) Stem cells, cancer, and cancer stem cells . Nature414(6859): 105-111.
31.
Runde, V. et al. (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant28: 51-57.
32.
Scotton, C.J. et al. (2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus, Chest132(4): 1311-1321.
33.
Sethe, S. (2006) Aging of mesenchymal stem cells. Ageing Res Rev5: 91-116.
34.
Shigehisa Yanagi et al. (2007) Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest117(10): 2929-2940.
35.
Shimabukuro, D.W. et al. (2003) Injury and repair in lung and airways. Crit Care Med31: S524-531.
36.
Siafakas, N.M. et al. (2007) Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis2(4): 453-462.
37.
Spees, J.L., et al. (2008) Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J22(4): 1226-1236.
38.
U.S. Centers for Disease Control and Prevention. (2002) National Vital Statistics Reports, Final Mortality .
39.
U.S. National Heart, Lung and Blood Institute, (2004).
40.
Wang, G. et al. (2005) Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis . Proc Natl Acad Sci USA102(1): 186-191.
41.
Weiss, D.J. (2007) Stem cells and cell therapies for cystic fibrosis and other lung diseases. Pulm Pharmacol Ther doi:10.1016/j.pupt.2007.11.004.
42.
Yen, C.C. et al. (2006) Stem cells in the lung parenchyma and prospects for lung injury therapy. Eur J Clin Invest36: 310-319.
